Home  |  Contact

UniProtKB/Swiss-Prot Q14789: Variant p.Gly1765Asp

Golgin subfamily B member 1
Gene: GOLGB1
Variant information

Variant position:  1765
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glycine (G) to Aspartate (D) at position 1765 (G1765D, p.Gly1765Asp).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from glycine (G) to medium size and acidic (D)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  1765
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  3259
The length of the canonical sequence.

Location on the sequence:   LMSEKDSLSEEVQDLKHQIE  G NVSKQANLEATEKHDNQTNV
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 3259 Golgin subfamily B member 1
Topological domain 1 – 3235 Cytoplasmic
Coiled coil 1301 – 1779


Literature citations

Macrogolgin -- a new 376 kD Golgi complex outer membrane protein as target of antibodies in patients with rheumatic diseases and HIV infections.
Seelig H.P.; Schranz P.; Schroeter H.; Wiemann C.; Griffiths G.; Renz M.;
J. Autoimmun. 7:67-91(1994)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANT ASP-1765;

Fine expression profiling of full-length transcripts using a size-unbiased cDNA library prepared with the vector-capping method.
Oshikawa M.; Sugai Y.; Usami R.; Ohtoko K.; Toyama S.; Kato S.;
DNA Res. 15:123-136(2008)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2); VARIANTS SER-911; CYS-1212 AND ASP-1765;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.